Deal Library / Pharma BD Deal Intelligence

Amgen Inc. — Pharma Deals

The Pharma Closeout tracks 17 deals, $101.4B in disclosed deal value, 13 with a post-close Outcome Score for Amgen Inc..

Median Critic Score: 75 · Median Outcome Score: 68

All 17 deals

Amgen Inc. / Immunex Corporation — 2002 · $16.0B · Worked — the deal delivered on its rationale.
Amgen Inc. / Immunex Corporation — 2001 · $16.0B · Worked — the deal delivered on its rationale.
Amgen Inc. / Micromet Inc. — 2012 · $1.2B · Worked — the deal delivered on its rationale.
Amgen Inc. / Five Prime Therapeutics — 2021 · $1.9B · Worked — the deal delivered on its rationale.
Amgen Inc. / Horizon Therapeutics plc — 2022 · $27.8B · Largely worked — most objectives met.
Amgen Inc. / BeiGene Ltd. — 2020 · $2.8B · Largely worked — most objectives met.
Amgen Inc. / Otezla (from Celgene/BMS) — 2019 · $13.4B · Largely worked — most objectives met.
Amgen Inc. / Onyx Pharmaceuticals — 2013 · $10.4B · Largely worked — most objectives met.
Amgen Inc. / ChemoCentryx Inc. — 2022 · $3.7B · Largely worked — most objectives met.
Amgen Inc. / Kinetix Pharmaceuticals Inc. — 2000 · $170M · Underwhelmed — fell short of the thesis.
Amgen Inc. / BioVex Group, Inc. — 2011 · $1.0B · Underwhelmed — fell short of the thesis.
Amgen Inc. / Tularik Inc. — 2004 · $1.3B · Underwhelmed — fell short of the thesis.
Amgen Inc. / Ilypsa Inc. — 2007 · $420M · Did not work — the deal failed to deliver.
Amgen Inc. / Teneobio, Inc. — 2021 · $2.5B
Amgen Inc. / Rodeo Therapeutics Corporation — 2021 · $721M
Amgen Inc. / Dezima Pharma B.V. — 2015 · $1.6B
Amgen Inc. / Kite Pharma, Inc. — 2015 · $585M